Molecular Stratification of Light-Chain Cardiac Amyloidosis With 18F-Florbetapir and 68Ga-FAPI-04 for Enhanced Prognostic Precision
Authors:
- 8 January 2025
- journal article
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 18 (3) , 323-336
Abstract
No abstract availableKeywords
Funding Information
- CAMS Innovation Fund for Medical Sciences
This publication has 18 references indexed in Scilit:
- Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatmentAmerican Journal of Hematology, 2023
- Fibroblast ActivationJACC: Cardiovascular Imaging, 2022
- Feasibility of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Light-Chain Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2022
- The utility of positron emission tomography in cardiac amyloidosisHeart Failure Reviews, 2021
- Multimodality imaging approach to cardiac amyloidosis: part 2Heart Failure Reviews, 2021
- Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain AmyloidosisJACC: Cardiovascular Imaging, 2020
- How to Image Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2020
- Multiparametric Echocardiography Scores for the Diagnosis of Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2020
- Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac AmyloidosisJACC, 2020
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisAmerican Journal of Hematology, 2005